RPRD1B and neoplasm: CREPT promotes β-catenin transcriptional activity by maintaining its interaction with the transcriptional co-activator and activating the activity of enhancers in a p300-dependent manner, increasing Wnt target gene expression, and facilitating tumor growth and development.